Addiction is a prevalent issue in the United States, impacting millions of Americans with substance use disorders. According to a national survey, approximately 1 in 12 American adults, or nearly 19 million people, grapple with a substance use disorder. Despite the daunting nature of this problem, there is assistance available for those struggling with alcohol or drug misuse.
A relatively recent concern in the realm of addiction is the rising number of individuals becoming addicted to benzodiazepines, commonly known as benzos. These medications, with calming or sedative effects, influence the brain and central nervous system. While benzos have proven highly useful in treating various physical and mental conditions, they possess addictive properties that often necessitate professional assistance to discontinue use.
The prevalence of benzodiazepine addiction is on the rise, with over 5 million Americans misusing benzos in 2015 alone. Emergency room visits related to benzodiazepine use increased by 150% from 2004 to 2011.
Benzodiazepines are a specific class of medication used to address various mental health and nervous system disorders. They enhance the body’s neurotransmitters, particularly the GABA neurotransmitter, which has a calming effect on the brain. Common benzodiazepines, such as Klonopin, Xanax, and Valium, are frequently prescribed to treat anxiety and panic disorders. Additionally, benzos are used for conditions like insomnia, seizure disorders, and alcohol withdrawal to help manage symptoms and reduce the risk of severe withdrawal effects.
While benzodiazepines are effective when used properly, they possess addictive properties. In addition to inducing calming effects, benzos stimulate the release of dopamine, a neurotransmitter associated with pleasure. Continued use may lead to tolerance, requiring higher doses to achieve the same effects. Tolerance can develop in as little as six months, prompting some individuals to turn to stronger substances like opioids. Dependence on benzodiazepines may result in withdrawal symptoms upon cessation, similar to those seen with alcohol and other drugs, including nausea, disorientation, sweating, irritability, and more.
Withdrawal symptoms from benzodiazepines are a genuine concern and may manifest in as little as a month of regular use. Approximately 40% of individuals using benzos for over six months will experience moderate or severe withdrawal symptoms, while 60% may experience milder symptoms. In severe cases, withdrawal can be life-threatening, emphasizing the importance of professional treatment when discontinuing the drug. Withdrawal symptoms vary among individuals, encompassing anxiety, panic attacks, irritability, depression, concentration issues, insomnia, and physical symptoms like tremors, muscle spasms, headaches, sweating, and muscle soreness. Medical professionals may recommend tapering off benzodiazepines gradually to manage withdrawal and minimize discomfort.
The duration of withdrawal varies, with milder forms peaking around the second day of detox and improving by the fourth or fifth day. However, 10% to 25% of users may experience protracted withdrawal lasting several weeks.
The chemical structure of benzodiazepines makes addiction likely, contributing to the estimated 30 million Americans using benzos annually, with at least 17% having misused them. Recognizable symptoms of benzodiazepine addiction include appearing drowsy, disoriented, or confused. Individuals may struggle with thinking or speaking, experience dizziness, slurred speech, and lack of coordination. Other signs mirror those of substance use disorders, including the perceived need for the drug to function, difficulties in daily activities without the substance, tolerance development, relationship challenges, performance issues, and attempts to conceal the extent of medication use. If left untreated, benzodiazepine addiction can lead to cognitive decline and a loss of physical coordination.
Professional treatment is crucial for successfully addressing benzodiazepine addiction. Screening for addiction involves questionnaires and DSM-V guidelines, with appropriate treatment tailored to individual needs. Outpatient or inpatient treatment may be recommended based on the risk of relapse, and benzodiazepine use during detox should be closely monitored. Gradual tapering, rather than abrupt cessation, is often recommended. Psychological treatment, including therapy and counseling, helps individuals identify triggers, manage stressors, and develop coping strategies for a healthier life. New Day Recovery, a residential treatment program in Louisiana offers specialized programs for overcoming substance use disorders, including benzodiazepine addiction.
Benzodiazepine addiction is a serious medical concern requiring professional intervention. Withdrawal can be managed, and addiction to these drugs can be overcome with appropriate treatment. New Day Recovery and similar programs provide comprehensive care to individuals seeking recovery from benzodiazepine addiction.
1416 Natchitoches Street
West Monroe, LA 71291
P: 318.900.7133
F: 318.855.8779
6240 Greenwood Road
Shreveport, LA 71119
P: 318.809.1640
F: 318.855.8779
Cookie | Duration | Description |
---|---|---|
__cf_bm | 1 hour | This cookie, set by Cloudflare, is used to support Cloudflare Bot Management. |
_GRECAPTCHA | 6 months | Google Recaptcha service sets this cookie to identify bots to protect the website against malicious spam attacks. |
.AspNetCore.Cookies | 11 months | This cookie is installed by BayMark Health Services, Inc. The cookie is used to maintain persistence with ChatGPT sessions. |
.AspNetCore.CookiesC1 | 11 months | This cookie is installed by BayMark Health Services, Inc. The cookie is used to maintain persistence with ChatGPT sessions. |
.AspNetCore.CookiesC2 | 11 months | This cookie is installed by BayMark Health Services, Inc. The cookie is used to maintain persistence with ChatGPT sessions. |
.AspNetCore.CookiesC3 | 11 months | This cookie is installed by BayMark Health Services, Inc. The cookie is used to maintain persistence with ChatGPT sessions. |
cookielawinfo-checkbox-advertisement | 1 year | Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Advertisement" category. |
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
CookieLawInfoConsent | 1 year | CookieYes sets this cookie to record the default button state of the corresponding category and the status of CCPA. It works only in coordination with the primary cookie. |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Cookie | Duration | Description |
---|---|---|
yt-player-headers-readable | never | The yt-player-headers-readable cookie is used by YouTube to store user preferences related to video playback and interface, enhancing the user's viewing experience. |
yt-remote-cast-available | session | The yt-remote-cast-available cookie is used to store the user's preferences regarding whether casting is available on their YouTube video player. |
yt-remote-cast-installed | session | The yt-remote-cast-installed cookie is used to store the user's video player preferences using embedded YouTube video. |
yt-remote-fast-check-period | session | The yt-remote-fast-check-period cookie is used by YouTube to store the user's video player preferences for embedded YouTube videos. |
yt-remote-session-app | session | The yt-remote-session-app cookie is used by YouTube to store user preferences and information about the interface of the embedded YouTube video player. |
yt-remote-session-name | session | The yt-remote-session-name cookie is used by YouTube to store the user's video player preferences using embedded YouTube video. |
ytidb::LAST_RESULT_ENTRY_KEY | never | The cookie ytidb::LAST_RESULT_ENTRY_KEY is used by YouTube to store the last search result entry that was clicked by the user. This information is used to improve the user experience by providing more relevant search results in the future. |
Cookie | Duration | Description |
---|---|---|
_ga | 1 year 1 month 4 days | Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors. |
_ga_* | 1 year 1 month 4 days | Google Analytics sets this cookie to store and count page views. |
CONSENT | 2 years | YouTube sets this cookie via embedded YouTube videos and registers anonymous statistical data. |
Cookie | Duration | Description |
---|---|---|
__ctmid | 1 month | CallTrackingMetrics sets this cookie to determine the advertising channel that led a visitor to the website and also show the tracking phone number that corresponds to that channel. |
test_cookie | 15 minutes | doubleclick.net sets this cookie to determine if the user's browser supports cookies. |
VISITOR_INFO1_LIVE | 5 months 27 days | YouTube sets this cookie to measure bandwidth, determining whether the user gets the new or old player interface. |
VISITOR_PRIVACY_METADATA | 6 months | YouTube sets this cookie to store the user's cookie consent state for the current domain. |
YSC | session | Youtube sets this cookie to track the views of embedded videos on Youtube pages. |
yt-remote-connected-devices | never | YouTube sets this cookie to store the user's video preferences using embedded YouTube videos. |
yt-remote-device-id | never | YouTube sets this cookie to store the user's video preferences using embedded YouTube videos. |
yt.innertube::nextId | never | YouTube sets this cookie to register a unique ID to store data on what videos from YouTube the user has seen. |
yt.innertube::requests | never | YouTube sets this cookie to register a unique ID to store data on what videos from YouTube the user has seen. |
Cookie | Duration | Description |
---|---|---|
ct241901 | session | Description is currently not available. |
ENTERPRISE_SESSION | 7 days | Description is currently not available. |
guest | 1 month | No description available. |
JOTFORM_SESSION | 1 month | No description available. |
userReferer | 1 month | No description available. |